首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >Biospecimen 'Ownership': Point Roberta B. Ness on behalf of the American College of Epidemiology Policy Committee Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
【24h】

Biospecimen 'Ownership': Point Roberta B. Ness on behalf of the American College of Epidemiology Policy Committee Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania

机译:生物样品“所有权”:Pointa Roberta B. Ness代表宾夕法尼亚州匹兹堡匹兹堡大学公共卫生研究生院美国流行病学政策委员会

获取原文
获取原文并翻译 | 示例
           

摘要

Biorepositories are rare and valuable resources, so it is perhaps not surprising that their "ownership" has been the focus of recent controversy and debate. From the vantage point of the epidemiologist, decisions about ownership or "custodianship" of biorepositories collected for research should be guided by a discrete set of principles (http:// www.acepidenuology2.org/policystmts). First, custodianship should encourage openness of scientific inquiry and should maximize biospecimen use and sharing so as to exploit the full potential to promote health. Second, the privacy of participants must be protected and informed consent must provide provisions for unanticipated biospecimen use. Third, the intellectual investment of investigators involved in the creation of a biorepository is often substantial and should be respected. Finally, sharing of specimens needs to protect proprietary information and to address the concerns of third-party funders.
机译:生物储存库是稀有且宝贵的资源,因此,其“所有权”一直是近期争议和辩论的焦点,这不足为奇。从流行病学家的角度出发,有关收集的用于研究的生物库所有权或“监护权”的决定应遵循一系列离散的原则(http://www.acepidenuol​​ogy2.org/policystmts)。首先,保管应鼓励科学询问的开放性,并应最大程度地利用和共享生物样本,以充分利用促进健康的潜力。其次,参与者的隐私必须得到保护,知情同意必须为意外使用的生物样本提供规定。第三,参与建立生物储存库的研究人员的智力投资通常是巨大的,应予以尊重。最后,标本共享需要保护专有信息并解决第三方出资者的担忧。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号